Back to Search
Start Over
Autologous Nonmyeloablative Hematopoietic Stem Cell Transplantation in Newly Diagnosed Type 1 Diabetes Mellitus.
- Source :
- JAMA: Journal of the American Medical Association; 4/11/2007, Vol. 297 Issue 14, p1568-1576, 9p, 3 Charts, 15 Graphs
- Publication Year :
- 2007
-
Abstract
- The article presents a clinical research study that examined the safety and metabolic effects of high-dose immunosuppression followed by autologous nonmyeloablative hematopoietic stem cell transplantation (AHST) in patients with newly diagnosed type 1 diabetes mellitus, which is the result of a cell-mediated autoimmune attack against pancreatic beta cells. The authors concluded that high-dose immunosuppression and AHST were performed with acceptable toxicity. Beta cell function was increased in almost all patients with AHST, which also induced prolonged insulin independence in the majority of patients.
Details
- Language :
- English
- ISSN :
- 00987484
- Volume :
- 297
- Issue :
- 14
- Database :
- Complementary Index
- Journal :
- JAMA: Journal of the American Medical Association
- Publication Type :
- Academic Journal
- Accession number :
- 24635198
- Full Text :
- https://doi.org/10.1001/jama.297.14.1568